NTI vs SLD

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

NTI

NEUROTECH FPO [NTI]

48LOW

SLD

SALUDA MED CDI FORUS [SLD]

48LOW

Score Breakdown

NTI SLD
Technical
51
57
Catalyst
66
50
Sentiment
50
50
Fundamental
70
73
Momentum
42
29
Risk Gate
31
50

Key Metrics

NTI Metric SLD
$14.3MMarket CapN/A
840KAvg Volume (20d)112K
N/AShort Interest+0.0%
$0.03752-Week High$1.900
$0.01052-Week Low$0.785
+9.1%Daily Change+1.9%
$0.012Entry Price$0.800
-66.3%ROEN/A
-54.4%Profit Margin-213.8%

Active Signals

NTI Signals

●Below the 200-day average — the long-term trend is still working against it
●Strong cash runway (9 quarters)
●Low P/S ratio (2.0x)
●Strong revenue growth (+4069%)
●Near 52-week low (4% of range)
●Micro-cap ($5-20M) - high risk
●Deeply negative margins (-54%)
●Not enough chatter to gauge sentiment — defaulting to neutral

SLD Signals

●RSI drifting toward oversold territory — worth watching
●Stochastic is deep in oversold territory — bounce conditions forming
●Trading below both moving averages — the trend is working against this one
●Volume surging at 3.6x normal while price falls — heavy selling pressure
●Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
●Drifting lower — down 3.0% over the last 5 days
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Adequate cash runway (5 quarters)

Ask Scout AI to compare NTI and SLD in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
NTI Full Analysis → SLD Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).